Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression

Charn Jung Chang, Chuan Chih Hsu, Ming Chi Yung, Kai Yun Chen, Ching Tzao, Wei Fong Wu, Hsiang Yun Chou, Yi Yen Lee, Kai Hsi Lu, Shih Hwa Chiou, Hsin I. Ma

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

CD133-expressing glioma cells play a critical role in tumor recovery after treatment and are resistant to radiotherapy. Herein, we demonstrated that glioblastoma-derived CD133-positive cells (GBM-CD133+) are capable of self-renewal and express high levels of embryonic stem cell genes and SirT1 compared to GBM-CD133- cells. To evaluate the role of SirT1 in GBM-CD133+, we used a lentiviral vector expressing shRNA to knock-down SirT1 expression (sh-SirT1) in GBM-CD133+. Silencing of SirT1 significantly enhanced the sensitivity of GBM-CD133+ to radiation and increased the level of radiation-mediated apoptosis. Importantly, knock-down of SirT1 increased the effectiveness of radiotherapy in the inhibition of tumor growth in nude mice transplanted with GBM-CD133+. Kaplan-Meier survival analysis indicated that the mean survival rate of GBM-CD133+ mice treated with radiotherapy was significantly improved by Sh-SirT1 as well. In sum, these results suggest that SirT1 is a potential target for increasing the sensitivity of GBM and glioblastoma-associated cancer stem cells to radiotherapy.

Original languageEnglish
Pages (from-to)236-242
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume380
Issue number2
DOIs
Publication statusPublished - Mar 6 2009
Externally publishedYes

Fingerprint

Radiation Tolerance
Radiotherapy
Glioma
Cells
Radiation
Apoptosis
Glioblastoma
Stem cells
Tumors
Neoplastic Stem Cells
Kaplan-Meier Estimate
Embryonic Stem Cells
Survival Analysis
Nude Mice
Small Interfering RNA
Neoplasms
Genes
Recovery
Growth
Therapeutics

Keywords

  • CD133
  • Glioblastoma
  • Radiotherapy
  • SirT1

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. / Chang, Charn Jung; Hsu, Chuan Chih; Yung, Ming Chi; Chen, Kai Yun; Tzao, Ching; Wu, Wei Fong; Chou, Hsiang Yun; Lee, Yi Yen; Lu, Kai Hsi; Chiou, Shih Hwa; Ma, Hsin I.

In: Biochemical and Biophysical Research Communications, Vol. 380, No. 2, 06.03.2009, p. 236-242.

Research output: Contribution to journalArticle

Chang, Charn Jung ; Hsu, Chuan Chih ; Yung, Ming Chi ; Chen, Kai Yun ; Tzao, Ching ; Wu, Wei Fong ; Chou, Hsiang Yun ; Lee, Yi Yen ; Lu, Kai Hsi ; Chiou, Shih Hwa ; Ma, Hsin I. / Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. In: Biochemical and Biophysical Research Communications. 2009 ; Vol. 380, No. 2. pp. 236-242.
@article{48f6d054a08a4c8c8f3118c74b8e6545,
title = "Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression",
abstract = "CD133-expressing glioma cells play a critical role in tumor recovery after treatment and are resistant to radiotherapy. Herein, we demonstrated that glioblastoma-derived CD133-positive cells (GBM-CD133+) are capable of self-renewal and express high levels of embryonic stem cell genes and SirT1 compared to GBM-CD133- cells. To evaluate the role of SirT1 in GBM-CD133+, we used a lentiviral vector expressing shRNA to knock-down SirT1 expression (sh-SirT1) in GBM-CD133+. Silencing of SirT1 significantly enhanced the sensitivity of GBM-CD133+ to radiation and increased the level of radiation-mediated apoptosis. Importantly, knock-down of SirT1 increased the effectiveness of radiotherapy in the inhibition of tumor growth in nude mice transplanted with GBM-CD133+. Kaplan-Meier survival analysis indicated that the mean survival rate of GBM-CD133+ mice treated with radiotherapy was significantly improved by Sh-SirT1 as well. In sum, these results suggest that SirT1 is a potential target for increasing the sensitivity of GBM and glioblastoma-associated cancer stem cells to radiotherapy.",
keywords = "CD133, Glioblastoma, Radiotherapy, SirT1",
author = "Chang, {Charn Jung} and Hsu, {Chuan Chih} and Yung, {Ming Chi} and Chen, {Kai Yun} and Ching Tzao and Wu, {Wei Fong} and Chou, {Hsiang Yun} and Lee, {Yi Yen} and Lu, {Kai Hsi} and Chiou, {Shih Hwa} and Ma, {Hsin I.}",
year = "2009",
month = "3",
day = "6",
doi = "10.1016/j.bbrc.2009.01.040",
language = "English",
volume = "380",
pages = "236--242",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression

AU - Chang, Charn Jung

AU - Hsu, Chuan Chih

AU - Yung, Ming Chi

AU - Chen, Kai Yun

AU - Tzao, Ching

AU - Wu, Wei Fong

AU - Chou, Hsiang Yun

AU - Lee, Yi Yen

AU - Lu, Kai Hsi

AU - Chiou, Shih Hwa

AU - Ma, Hsin I.

PY - 2009/3/6

Y1 - 2009/3/6

N2 - CD133-expressing glioma cells play a critical role in tumor recovery after treatment and are resistant to radiotherapy. Herein, we demonstrated that glioblastoma-derived CD133-positive cells (GBM-CD133+) are capable of self-renewal and express high levels of embryonic stem cell genes and SirT1 compared to GBM-CD133- cells. To evaluate the role of SirT1 in GBM-CD133+, we used a lentiviral vector expressing shRNA to knock-down SirT1 expression (sh-SirT1) in GBM-CD133+. Silencing of SirT1 significantly enhanced the sensitivity of GBM-CD133+ to radiation and increased the level of radiation-mediated apoptosis. Importantly, knock-down of SirT1 increased the effectiveness of radiotherapy in the inhibition of tumor growth in nude mice transplanted with GBM-CD133+. Kaplan-Meier survival analysis indicated that the mean survival rate of GBM-CD133+ mice treated with radiotherapy was significantly improved by Sh-SirT1 as well. In sum, these results suggest that SirT1 is a potential target for increasing the sensitivity of GBM and glioblastoma-associated cancer stem cells to radiotherapy.

AB - CD133-expressing glioma cells play a critical role in tumor recovery after treatment and are resistant to radiotherapy. Herein, we demonstrated that glioblastoma-derived CD133-positive cells (GBM-CD133+) are capable of self-renewal and express high levels of embryonic stem cell genes and SirT1 compared to GBM-CD133- cells. To evaluate the role of SirT1 in GBM-CD133+, we used a lentiviral vector expressing shRNA to knock-down SirT1 expression (sh-SirT1) in GBM-CD133+. Silencing of SirT1 significantly enhanced the sensitivity of GBM-CD133+ to radiation and increased the level of radiation-mediated apoptosis. Importantly, knock-down of SirT1 increased the effectiveness of radiotherapy in the inhibition of tumor growth in nude mice transplanted with GBM-CD133+. Kaplan-Meier survival analysis indicated that the mean survival rate of GBM-CD133+ mice treated with radiotherapy was significantly improved by Sh-SirT1 as well. In sum, these results suggest that SirT1 is a potential target for increasing the sensitivity of GBM and glioblastoma-associated cancer stem cells to radiotherapy.

KW - CD133

KW - Glioblastoma

KW - Radiotherapy

KW - SirT1

UR - http://www.scopus.com/inward/record.url?scp=60349085855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60349085855&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.01.040

DO - 10.1016/j.bbrc.2009.01.040

M3 - Article

C2 - 19166820

AN - SCOPUS:60349085855

VL - 380

SP - 236

EP - 242

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -